224 related articles for article (PubMed ID: 14984920)
1. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Roe MT; Mahaffey KW; Kilaru R; Alexander JH; Akkerhuis KM; Simoons ML; Harrington RA; Tardiff BE; Granger CB; Ohman EM; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Topol EJ
Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
[TBL] [Abstract][Full Text] [Related]
2. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
Mahaffey KW; Roe MT; Kilaru R; Alexander JH; Van de Werf F; Califf RM; Simoons ML; Topol EJ; Harrington RA
Eur Heart J; 2007 Feb; 28(4):425-32. PubMed ID: 17267458
[TBL] [Abstract][Full Text] [Related]
3. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
[TBL] [Abstract][Full Text] [Related]
4. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
[TBL] [Abstract][Full Text] [Related]
5. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.
Yan AT; Yan RT; Tan M; Chow CM; Fitchett D; Stanton E; Langer A; Goodman SG;
Eur Heart J; 2004 Nov; 25(22):2006-12. PubMed ID: 15541836
[TBL] [Abstract][Full Text] [Related]
6. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.
Newby LK; Roe MT; Chen AY; Ohman EM; Christenson RH; Pollack CV; Hoekstra JW; Peacock WF; Harrington RA; Jesse RL; Gibler WB; Peterson ED;
J Am Coll Cardiol; 2006 Jan; 47(2):312-8. PubMed ID: 16412853
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
8. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
[TBL] [Abstract][Full Text] [Related]
11. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.
Ramsay J; Shernan S; Fitch J; Finnegan P; Todaro T; Filloon T; Nussmeier NA
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):300-6. PubMed ID: 15678039
[TBL] [Abstract][Full Text] [Related]
12. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
13. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
14. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
[TBL] [Abstract][Full Text] [Related]
15. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
Chang SM; Yazbek N; Lakkis NM
Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE).
Goodman SG; Steg PG; Eagle KA; Fox KA; López-Sendón J; Montalescot G; Budaj A; Kennelly BM; Gore JM; Allegrone J; Granger CB; Gurfinkel EP;
Am Heart J; 2006 Mar; 151(3):654-60. PubMed ID: 16504627
[TBL] [Abstract][Full Text] [Related]
17. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
[TBL] [Abstract][Full Text] [Related]
18. Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes.
Novack V; Jotkowitz AB; Cutlip D; Amit G; Liebermann N; Porath A
Postgrad Med J; 2008 Jan; 84(987):50-5. PubMed ID: 18230752
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction.
Halkin A; Stone GW; Grines CL; Cox DA; Rutherford BD; Esente P; Meils CM; Albertsson P; Farah A; Tcheng JE; Lansky AJ; Mehran R
J Am Coll Cardiol; 2006 Mar; 47(5):951-61. PubMed ID: 16516077
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
